Skip Navigation


Brain Advance Access originally published online on May 5, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
127/6/1361    most recent
awh153v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (57)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fernando, K. T. M.
Right arrow Articles by Miller, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernando, K. T. M.
Right arrow Articles by Miller, D. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 127, No. 6, 1361-1369, 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh153

Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis

K. T. M. Fernando1, M. A. McLean2, D. T. Chard1, D. G. MacManus1, C. M. Dalton1, K. A. Miszkiel3, R. M. Gordon1, G. T. Plant3,4, A. J. Thompson1 and D. H. Miller1

1 NMR Research Unit and 2 Epilepsy Research Unit, Institute of Neurology, 3 National Hospital for Neurology and Neurosurgery, and 4 Moorfields Eye Hospital, London, UK

Correspondence to: Kryshani T. M. Fernando, Institute of Neurology, Queen Square, London WC1N 3BG, UK. E-mail: k.fernando{at}ion.ucl.ac.uk

Normal-appearing white matter (NAWM) in established multiple sclerosis has been shown to be abnormal using a variety of magnetic resonance (MR) techniques, including proton MR spectroscopy (1H-MRS), although the stage at which these changes first appear is less clear. Using a 1.5 T scanner and single-voxel 1H-MRS [TR 3000 ms, TE 30 ms, point-resolved spectroscopy (PRESS) localization], we determined NAWM metabolite concentrations in 96 patients a mean of 19 weeks (range 12–28 weeks) after onset of a clinically isolated syndrome (CIS) suggestive of multiple sclerosis and in 44 healthy control subjects. Absolute concentrations of N-acetyl-aspartate, total creatine and phosphocreatine (Cr), choline-containing compounds, glutamate plus glutamine, and myo-inositol (Ins) were estimated automatically using the LCModel. Compared with control subjects, the concentration of Ins was elevated in CIS NAWM (mean 3.31 mM, SD 0.86 versus mean 3.82 mM, SD 1.06; P = 0.001). The increase in Ins was also seen in the patient subgroup with abnormal T2-weighted MRI (mean 3.88 mM, SD 1.10; P = 0.001) and in those who satisfied the McDonald criteria for multiple sclerosis (mean 4.04 mM, SD 1.31; P = 0.001). An increase in Cr was also observed in CIS NAWM (P = 0.023), but other metabolites did not significantly differ between the whole CIS group and control subjects. There was no significant correlation between NAWM Ins and T2 lesion load. The early increase in Ins may reflect a process of pathogenic importance in multiple sclerosis NAWM. Follow-up studies will investigate whether the increase in NAWM Ins is of prognostic importance for future relapses and disability.

Key Words: MRS, NAWM; myo-inositol; multiple sclerosis; clinically isolated syndromes

Abbreviations: CIS = clinically isolated syndrome; Cho = choline; Cr = creatine and phosphocreatine; EDSS = Expanded Disability Status Scale; Glx = glutamate and glutamine; 1H-MRS = proton magnetic resonance spectroscopy; Ins = myo-inositol; MTR = magnetization transfer ratio; NAWM = normal appearing white matter; TE = echo time; TR = repetition time; tNAA = total N-acetyl-aspartate

Received November 14, 2003. Revised January 21, 2004. Accepted January 27, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
J. K. Swanton, K. T. Fernando, C. M. Dalton, K. A. Miszkiel, D. R. Altmann, G. T. Plant, A. J. Thompson, and D. H. Miller
Early MRI in optic neuritis: The risk for disability
Neurology, February 10, 2009; 72(6): 542 - 550.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M Summers, J Swanton, K Fernando, C Dalton, D H Miller, L Cipolotti, and M A Ron
Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 955 - 958.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
L. K. Fisniku, P. A. Brex, D. R. Altmann, K. A. Miszkiel, C. E. Benton, R. Lanyon, A. J. Thompson, and D. H. Miller
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
Brain, March 1, 2008; 131(3): 808 - 817.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N. De Stefano, M. Filippi, D. Miller, P. J. Pouwels, A. Rovira, A. Gass, C. Enzinger, P. M. Matthews, and D. L. Arnold
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies
Neurology, November 13, 2007; 69(20): 1942 - 1952.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
M.P. Wattjes, M. Harzheim, G.G. Lutterbey, L. Klotz, H.H. Schild, and F. Traber
Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy
AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1517 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
O. Ciccarelli, C.A. Wheeler-Kingshott, M.A. McLean, M. Cercignani, K. Wimpey, D.H. Miller, and A.J. Thompson
Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis
Brain, August 1, 2007; 130(8): 2220 - 2231.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
D. Soon, D. Tozer, D. Altmann, P. Tofts, and D. Miller
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes
Multiple Sclerosis, August 1, 2007; 13(7): 884 - 894.
[Abstract] [PDF]

Home page
 Mult SclerHome page
B Audoin, D Ibarrola, I Malikova, E Soulier, S Confort-Gouny, M-V A. Duong, F Reuter, P Viout, A Ali-Cherif, P J Cozzone, et al.
Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/MRSI study of corpus callosum
Multiple Sclerosis, January 1, 2007; 13(1): 41 - 51.
[Abstract] [PDF]

Home page
 RadiologyHome page
J. F. A. Jansen, W. H. Backes, K. Nicolay, and M. E. Kooi
1H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites.
Radiology, August 1, 2006; 240(2): 318 - 332.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
D.R. Amstutz, S.W. Coons, J.F. Kerrigan, H.L. Rekate, and J.E. Heiserman
Hypothalamic hamartomas: Correlation of MR imaging and spectroscopic findings with tumor glial content.
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 794 - 798.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
E. M. Frohman, E. Havrdova, F. Lublin, F. Barkhof, A. Achiron, M. K. Sharief, O. Stuve, M. K. Racke, L. Steinman, H. Weiner, et al.
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Arch Neurol, April 1, 2006; 63(4): 614 - 619.
[Full Text] [PDF]

Home page
 BrainHome page
K. T. M. Fernando, D. J. Tozer, K. A. Miszkiel, R. M. Gordon, J. K. Swanton, C. M. Dalton, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller
Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis
Brain, December 1, 2005; 128(12): 2911 - 2925.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Rovaris, A. Gambini, A. Gallo, A. Falini, A. Ghezzi, B. Benedetti, M. P. Sormani, V. Martinelli, G. Comi, and M. Filippi
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution
Neurology, November 22, 2005; 65(10): 1626 - 1630.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
Z. Caramanos, S. Narayanan, and D. L. Arnold
1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review
Brain, November 1, 2005; 128(11): 2483 - 2506.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
P. Pantano, C. Mainero, D. Lenzi, F. Caramia, G. D. Iannetti, M. C. Piattella, I. Pestalozza, S. Di Legge, L. Bozzao, and C. Pozzilli
A longitudinal fMRI study on motor activity in patients with multiple sclerosis
Brain, September 1, 2005; 128(9): 2146 - 2153.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Gallo, M. Rovaris, R. Riva, A. Ghezzi, B. Benedetti, V. Martinelli, A. Falini, G. Comi, and M. Filippi
Diffusion-Tensor Magnetic Resonance Imaging Detects Normal-Appearing White Matter Damage Unrelated to Short-term Disease Activity in Patients at the Earliest Clinical Stage of Multiple Sclerosis
Arch Neurol, May 1, 2005; 62(5): 803 - 808.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
R. Srinivasan, N. Sailasuta, R. Hurd, S. Nelson, and D. Pelletier
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
Brain, May 1, 2005; 128(5): 1016 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. Sastre-Garriga, G. T. Ingle, D. T. Chard, Li. Ramio-Torrenta, M. A. McLean, D. H. Miller, and A. J. Thompson
Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple Sclerosis
Arch Neurol, April 1, 2005; 62(4): 569 - 573.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Tiberio, D. T. Chard, D. R. Altmann, G. Davies, C. M. Griffin, W. Rashid, J. Sastre-Garriga, A. J. Thompson, and D. H. Miller
Gray and white matter volume changes in early RRMS: A 2-year longitudinal study
Neurology, March 22, 2005; 64(6): 1001 - 1007.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.